RPL5P10

Across TCGA pan-cancer cohorts, RPL5P10 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of RPL5P10’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where RPL5P10 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RPL5P10 is over-expressed in tumor, although a few such as BRCA show the opposite, repressed pattern.

COAD, BRCA, and LUSC are the cancer types where RPL5P10 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPL5P10 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	All	All	+0.178	.002	7	view →
BRCA	All	II,III,IV	−0.014	.036	2	view →
LUSC	Male	III,IV	+0.057	.038	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

RPL5P10–COAD

Open the COAD breakdown →